Medical radioisotopes for the next century
| dc.contributor.author | Carr, SW | en_AU |
| dc.date.accessioned | 2026-04-24T04:04:15Z | en_AU |
| dc.date.issued | 1999-10-27 | en_AU |
| dc.date.statistics | 2025-01-13 | en_AU |
| dc.description | Physical copy held by ANSTO Library at DDC: 621.48/10. | en_AU |
| dc.description.abstract | Radioisotopes are widely used in medicine (Nuclear Medicine) for diagnosis, palliation and therapy of heart disease, cancer, muscoskeletal and neurological conditions. The radioisotopes used are both reactor and cyclotron produced. The utilisation is currently growing and is expected to continue to grow over the next 10-20 years. The combination of radioisotope and delivery vehicle can be designed to meet the intended end use. This paper will deal with the main approaches to the use of radioisotopes for Nuclear medicine ad future prospects for the area. | en_AU |
| dc.identifier.booktitle | ANA 99: third Conference on Nuclear Science & Engineering in Australia, Rydges Canberra Hotel, Canberra A.C.T. Australia, 27-28 October 1999 conference handbook : theme, a nuclear renaissance. | en_AU |
| dc.identifier.citation | Carr. S. W. (1999). Medical radioisotopes for the next century. Paper presented to ANA 99 "Third Conference on Nucelar Science & Engeering in Australia", Canberra, ACT, Australia, 27-28 October 1999. In ANA Conference on Nuclear Science & Engineering in Australia, & Australian Nuclear Association. (1999). ANA 99: Third Conference on Nuclear Science & Engineering in Australia, Rydges Canberra Hotel, Canberra A.C.T. Australia, 27-28 October 1999: conference handbook: theme, a nuclear renaissance (pp. 81-84). Canberra, ACT : Australian Nuclear Association. | en_AU |
| dc.identifier.conferenceenddate | 1999-10-28 | en_AU |
| dc.identifier.conferencename | ANA 99: third Conference on Nuclear Science & Engineering in Australia, : "theme, a nuclear renaissance". | en_AU |
| dc.identifier.conferenceplace | Canberra, ACT | en_AU |
| dc.identifier.conferencestartdate | 1999-10-27 | en_AU |
| dc.identifier.isbn | 0949188123 | en_AU |
| dc.identifier.pagination | 81-84 | en_AU |
| dc.identifier.placeofpublication | Canberra, ACT | en_AU |
| dc.identifier.uri | https://apo.ansto.gov.au/handle/10238/17182 | en_AU |
| dc.language.iso | en | en_AU |
| dc.publisher | Australian Nuclear Association | en_AU |
| dc.subject | Diagnostic uses | en_AU |
| dc.subject | Labelled compounds | en_AU |
| dc.subject | Monoclonal Antibodies | en_AU |
| dc.subject | Nuclear medicine | en_AU |
| dc.subject | Peptides | en_AU |
| dc.subject | Radiopharmaceuticals | en_AU |
| dc.subject | Therapeutic uses | en_AU |
| dc.subject | Radioactive materials | en_AU |
| dc.subject | Uses | en_AU |
| dc.title | Medical radioisotopes for the next century | en_AU |
| dc.type | Conference Paper | en_AU |